Home/Publication/Saisei Ventures Leads in CAR-T Cancer Therapy
Saisei Ventures Leads in CAR-T Cancer Therapy 

17 Jan 2025

US$ 19.00

Saisei Ventures has led the ¥1.3 billion (US$8.4 million) series A investment in Optieum Biotechnologies Inc (Optieum),...

Price / article: US$19.00
OR existing subscriber
Related Publications
Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.